So that makes a loss for BTA of around $15mill for the year? The GSK royalty payment didn't even cover the legal expenses for the year. Good luck to the holders of this one.
PV1 Provaris tells ASX non-binding MOUs are still material to share prices in somewhat fiery compliance response